{
  "docId": "019de511-70b9-744d-9fdd-cb0d25e1c298",
  "docSlug": "65af9093c9ec9ca745928fa125179681",
  "documentTitle": "Avantor | Investor Day Presentation Deck | 89 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 39,
  "pageCount": 89,
  "prevPage": 38,
  "nextPage": 40,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 5,
  "notes": "The slide uses a bar chart to show growth and circular callouts to highlight key performance metrics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-70b9-744d-9fdd-cb0d25e1c298/39",
  "deckHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298",
  "deckJsonHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298.json",
  "deckAnchorHref": "/decks/019de511-70b9-744d-9fdd-cb0d25e1c298#slide-39",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.58,
        "x": 0.03,
        "y": 0.193
      },
      "kind": "chart",
      "text": "Biopharma production open orders growth from YE 2019 to Q2 2021",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19060f61-00ef-4b8c-bca6-9ae4e40de691",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.845,
        "y": 0.75
      },
      "kind": "metric",
      "text": "40% single-use solutions",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0df16a9b-00d6-40d6-b647-e7a93517001f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.15,
        "x": 0.81,
        "y": 0.295
      },
      "kind": "metric",
      "text": "5X growth from YE 2019",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "23c37ba8-2a72-4b92-8e8c-709fe2102254",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.15,
        "x": 0.684,
        "y": 0.462
      },
      "kind": "metric",
      "text": "80% base business (non-COVID)",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "354c063f-34f8-4a66-b6f9-432264fda9cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.1,
        "x": 0.684,
        "y": 0.75
      },
      "kind": "metric",
      "text": "60% high purity chemicals",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8f4da58-fc7b-4bb9-af51-0af5198e3564",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.22,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Growth from YE 2019 to Q2 2021\n2. Open order book figures as of Q2 2021",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3f7874d-5cae-4002-a0a8-752a3a496bc5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Rapid growth in open order book",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2cc16c39-9770-4cdc-9489-60b05a65dd73",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 89,
      "from": 17,
      "beatId": "2aa3ce3e-d4bb-4cda-b13e-25db1a3054af",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "Growth prospects and financial highlights",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 40,
      "from": 21,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "44a7c149-2da8-4925-9541-064336919963",
      "evidence": "Case study and supporting data",
      "position": 0,
      "objective": "Show how Avantor's offering supports Biopharma R&D activities",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}